Glycolate Oxidase Is a Safe and Efficient Target for Substrate Reduction Therapy in a Mouse Model of Primary Hyperoxaluria Type I

Cristina Martín-Higueras(Centre for Biomedical Network Research on Rare Diseases), Sergio Luis‐Lima(Universidad de La Laguna), Eduardo Salido(Universidad de La Laguna)

Molecular Therapy

December 22, 2015

10.1038/mt.2015.224

Cited by 82Open Access

Abstract

Related Papers

Primary hyperoxalurias: Disorders of glyoxylate detoxification

Eduardo Salido, Ángel L. Pey, Rosa Rodriguez et al.|Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease|2012|172

GLYOXYLATE SYNTHESIS, AND ITS MODULATION AND INFLUENCE ON OXALATE SYNTHESIS

Ross P. Holmes, Dean G. Assimos|The Journal of Urology|1998|163

Hydroxyproline ingestion and urinary oxalate and glycolate excretion

John Knight, Juquan Jiang, Dean G. Assimos et al.|Kidney International|2006|157

GLYOXYLATE SYNTHESIS, AND ITS MODULATION AND INFLUENCE ON OXALATE SYNTHESIS

Ross P. Holmes, Dean G. Assimos|The Journal of Urology|1998|145

Alanine–glyoxylate aminotransferase-deficient mice, a model for primary hyperoxaluria that responds to adenoviral gene transfer

Eduardo Salido, Xiao M. Li, Yang Lü et al.|Proceedings of the National Academy of Sciences|2006|125